Literature DB >> 9874664

Humoral response in Toscana virus acute neurologic disease investigated by viral-protein-specific immunoassays.

F Magurano1, L Nicoletti.   

Abstract

The Toscana virus (family Bunyaviridae, genus Phlebovirus) is the only sandfly-transmitted virus that demonstrates neurotropic activity. Clinical cases ranging from aseptic meningitis to meningoencephalitis caused by Toscana virus are yearly observed in central Italy during the summer, and several cases have been reported among tourists returning from zones of endemicity (Italy, Portugal, Spain, and Cyprus). In Toscana virus patients, immunoglobulin M (IgM) antibodies, usually present at the onset of symptoms, can reveal elevated titers by enzyme-linked immunosorbent assay and can persist for at least 1 year. IgG antibodies can be absent at the onset of symptoms: titers rise in convalescent sera and persist for many years. At least five proteins have been identified in Toscana virus-infected cells: nucleoprotein N, glycoproteins G1 and G2, a large protein (L) assumed to be a component of the polymerase, and two nonstructural proteins, NSm and NSs. We report results of a study on the antibody response to individual viral proteins in patients with Toscana virus-associated acute neurologic disease. Immunoblotting and semiquantitative radioimmunoprecipitation assay (RIPA) allow identification of nucleoprotein N as the major antigen responsible for both IgM and IgG responses. Antibodies to proteins other than nucleoprotein N are detected only by RIPA. Antibodies to glycoproteins are detected in about one-third of patients, and whereas their presence always predicts neutralization, some serum samples with neutralizing activity have undetectable levels of antibodies to G1-G2. Antibodies to nonstructural proteins NSm and NSs are also identified. The results obtained raise some questions about antigenic variability and relevant neutralization epitopes of Toscana virus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9874664      PMCID: PMC95660          DOI: 10.1128/CDLI.6.1.55-60.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  24 in total

1.  Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.

Authors:  C S Schmaljohn; Y K Chu; A L Schmaljohn; J M Dalrymple
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Antigenic relationship between hantaviruses analysed by immunoprecipitation.

Authors:  H Sheshberadaran; B Niklasson; E A Tkachenko
Journal:  J Gen Virol       Date:  1988-10       Impact factor: 3.891

3.  Enzyme-linked immunosorbent assay for determination of antibodies to the envelope glycoprotein of rabies virus.

Authors:  M Grassi; A I Wandeler; E Peterhans
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

4.  Synthesis of proteins and glycoproteins in dengue type 2 virus-infected vero and Aedes albopictus cells.

Authors:  G W Smith; P J Wright
Journal:  J Gen Virol       Date:  1985-03       Impact factor: 3.891

5.  Toscana virus infection in United States citizen returning from Italy.

Authors:  C H Calisher; A N Weinberg; D J Muth; J S Lazuick
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

6.  Neurovirulent Toscana virus (a sandfly fever virus) in Swedish man after visit to Portugal.

Authors:  A Ehrnst; C J Peters; B Niklasson; A Svedmyr; B Holmgren
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

7.  Ecology of viruses isolated from sand flies in Italy and characterized of a new Phlebovirus (Arabia virus).

Authors:  P Verani; M G Ciufolini; S Caciolli; A Renzi; L Nicoletti; G Sabatinelli; D Bartolozzi; G Volpi; L Amaducci; M Coluzzi
Journal:  Am J Trop Med Hyg       Date:  1988-03       Impact factor: 2.345

8.  Immunoblot analysis of the serological response in Hantavirus infections.

Authors:  L Zöller; J Scholz; R Stohwasser; L B Giebel; K K Sethi; E K Bautz; G Darai
Journal:  J Med Virol       Date:  1989-03       Impact factor: 2.327

9.  Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses.

Authors:  C Giorgi; L Accardi; L Nicoletti; M C Gro; K Takehara; C Hilditch; S Morikawa; D H Bishop
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

10.  Immune spleen cell-mediated protection against fatal Hantaan virus infection in infant mice.

Authors:  T Nakamura; R Yanagihara; C J Gibbs; D C Gajdusek
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

View more
  22 in total

1.  Detection of Toscana virus-specific immunoglobulins G and M by an enzyme-linked immunosorbent assay based on recombinant viral nucleoprotein.

Authors:  M G Ciufolini; C Fiorentini; P di Bonito; S Mochi; C Giorgi
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

Authors:  Bonto Faburay; William Wilson; D Scott McVey; Barbara S Drolet; Hana Weingartl; Daniel Madden; Alan Young; Wenjun Ma; Juergen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-20       Impact factor: 2.133

3.  Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay.

Authors:  Yongjun Jiao; Xiaoyan Zeng; Xiling Guo; Xian Qi; Xiao Zhang; Zhiyang Shi; Minghao Zhou; Changjun Bao; Wenshuai Zhang; Yan Xu; Hua Wang
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

4.  Performance of various commercial assays for the detection of Toscana virus antibodies.

Authors:  Koray Ergünay; Nadine Litzba; Modou Moustapha Lo; Sibel Aydoğan; Mehmet B Saygan; Dürdal Us; Manfred Weidmann; Matthias Niedrig
Journal:  Vector Borne Zoonotic Dis       Date:  2011-03-11       Impact factor: 2.133

5.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

Review 6.  A Mediterranean arbovirus: the Toscana virus.

Authors:  Marcello Valassina; Maria Grazia Cusi; Pier Egisto Valensin
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

7.  Development and Characterization of Monoclonal Antibodies Directed Against the Nucleoprotein of Heartland Virus.

Authors:  Amanda E Calvert; Aaron C Brault
Journal:  Am J Trop Med Hyg       Date:  2015-10-26       Impact factor: 2.345

Review 8.  Emergence of Toscana virus in Europe.

Authors:  Rémi N Charrel; Pierre Gallian; José-María Navarro-Mari; Loredana Nicoletti; Anna Papa; Mária Paz Sánchez-Seco; Antonio Tenorio; Xavier de Lamballerie
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

9.  Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.

Authors:  Petrus Jansen van Vuren; Caroline T Tiemessen; Janusz T Paweska
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

10.  Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies.

Authors:  Li Yu; Li Zhang; Lina Sun; Jing Lu; Wei Wu; Chuan Li; Quanfu Zhang; Fushun Zhang; Cong Jin; Xianjun Wang; Zhenqiang Bi; Dexin Li; Mifang Liang
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.